Donegan Michael C (CIK 0001627810)

Latest company ownership

Role: Prin. Fin. and Acctg. Officer
Shares held
50,000
Last filed at
Apr 14, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 26, 2023 Jan 30, 2023 TherapeuticsMD, Inc. Prin. Fin. and Acctg. Officer Sell 27.5 -1,697 -12.52% $8.6K
Jan 23, 2023 Jan 25, 2023 TherapeuticsMD, Inc. Prin. Fin. and Acctg. Officer Sell 27.5 -1,309 -14.68% $7K
Dec 6, 2022 Dec 9, 2022 TherapeuticsMD, Inc. CFO Sell 27.5 -910 -16.65% $4.3K
Nov 30, 2021 Dec 2, 2021 TherapeuticsMD, Inc. CAO and VP of Finance Sell 26.3 -29,790 -23.06% $15.9K
May 10, 2021 May 12, 2021 TherapeuticsMD, Inc. CAO and VP Finance Sell 27.5 -4,842 -25.48% $5K